Conditionally replicating adenovirus expressing TIMP2 for ovarian cancer therapy. - Wikidata - awgldk - TriplyDB

Conditionally replicating adenovirus expressing TIMP2 for ovarian cancer therapy.

Conditionally replicating adenovirus expressing TIMP2 for ovarian cancer therapy.

http://www.wikidata.org/entity/Q37277441

about

shRNA-armed conditionally replicative adenoviruses: a promising approach for cancer therapy EZH2-mediated epigenetic silencing of TIMP2 promotes ovarian cancer migration and invasion.Conditionally replicating adenovirus expressing TIMP2 increases survival in a mouse model of disseminated ovarian cancer Endogenous angiogenesis inhibitor blocks tumor growth via direct and indirect effects on tumor microenvironment.Oncolytic virotherapy for ovarian cancer.Virotherapy using a novel chimeric oncolytic adenovirus prolongs survival in a human pancreatic cancer xenograft model.A tumor-stroma targeted oncolytic adenovirus replicated in human ovary cancer samples and inhibited growth of disseminated solid tumors in mice.Optimization and preclinical design of genetically engineered viruses for human oncolytic therapy.Recent advances in oncolytic adenovirus therapies for cancer.Multimerization of adenovirus serotype 3 fiber knob domains is required for efficient binding of virus to desmoglein 2 and subsequent opening of epithelial junctions.The targeted inhibitory effects of human amniotic fluid stem cells carrying CXCR4 promoter and DAL-1 on non-small cell lung carcinoma growth.Ki67 targeted strategies for cancer therapy.The Many Facets of Metzincins and Their Endogenous Inhibitors: Perspectives on Ovarian Cancer Progression.

P2860

Q26765364-56091D35-C014-4881-A722-13A01CE52E7C Q33804215-6E6AB850-D296-4C8B-8EF1-0B036863D3B2 Q34055529-BD5FDC7B-300C-4D00-B1A3-4CD442AC9DF6 Q35475215-F3030538-56CE-4E32-8DB7-5B428C39E745 Q35597082-10422A64-22CC-49E6-BA08-68750D47BCD7 Q36205238-EAE01320-9D13-4E74-A1E1-F2E32557A4F4 Q36460449-A362D0F5-4C70-4728-AE75-D4C1740B8054 Q38025696-2C5C5FE6-6597-449B-B8BE-C3D311A7CDAE Q38886593-11D8FBD1-E56D-4E84-8A02-154A8715541C Q39551866-5415C34A-F228-49A8-B87C-710E7518148F Q41048929-C310E50F-A7CD-4101-9914-9BD673778949 Q45873470-DFF04805-55FA-4DCD-B407-F64AFCB1E75C Q49375848-1FFED29F-8711-4FEA-82C6-672188E44296

P2860

Conditionally replicating adenovirus expressing TIMP2 for ovarian cancer therapy.

http://www.wikidata.org/entity/Q37277441

description

2010 nî lūn-bûn

@nan

2010年の論文

@ja

2010年学术文章

@wuu

2010年学术文章

@zh-cn

2010年学术文章

@zh-hans

2010年学术文章

@zh-my

2010年学术文章

@zh-sg

2010年學術文章

@yue

2010年學術文章

@zh

2010年學術文章

@zh-hant

name

Conditionally replicating adenovirus expressing TIMP2 for ovarian cancer therapy.

@en

Conditionally replicating adenovirus expressing TIMP2 for ovarian cancer therapy.

@nl

type

label

Conditionally replicating adenovirus expressing TIMP2 for ovarian cancer therapy.

@en

Conditionally replicating adenovirus expressing TIMP2 for ovarian cancer therapy.

@nl

prefLabel

Conditionally replicating adenovirus expressing TIMP2 for ovarian cancer therapy.

@en

Conditionally replicating adenovirus expressing TIMP2 for ovarian cancer therapy.

@nl

P1433

Q37277441-55C15072-5037-4AD8-9444-D82D9320512F

P1476

Q37277441-84E7E25A-C78C-4647-A077-BA44087DD92A

P2093

Q37277441-7A6E20EC-AA1B-4040-9D2A-6202C6AD6AFC

Q37277441-A1F6EACB-3644-4F4C-B6CA-37397EC506EE

Q37277441-BC246E39-5080-4E1F-87F2-F2EDFCF68EE4

Q37277441-BC869221-1F9A-42AA-BE4C-FE5E37647763

Q37277441-D1DDB8D6-9EE5-4BEE-BED3-0BF4C491DE81

Q37277441-DC86C0DA-DFAD-47A6-974E-C67E9F0B6259

Q37277441-E5F847B5-F4D8-465A-840B-8B2DD79ABF77

Q37277441-ECDBE67C-5946-44A6-81B1-D1BF553E940D

Q37277441-F1AD1F47-D938-4D4A-8A24-AE18BA60F493

P2860

Q37277441-07072DA8-8B03-4AE7-BA35-8DDED4655221

Q37277441-11C4EE9F-059E-4E60-84AB-761A2FC8B7FF

Q37277441-1B5E792B-D4BD-416E-BCE6-33FDD072ABAC

Q37277441-42A37259-57C4-404D-A424-5A30B127A51A

Q37277441-4A1A3F80-5B06-4877-A954-8B9658608C50

Q37277441-52954A6E-E204-4765-9993-8713A816CF3E

Q37277441-55C6B806-F801-430C-85EF-28774A0789C5

Q37277441-68D8E6AD-54B9-45B1-AAA3-91D6F3B6E30C

Q37277441-7C0DD26E-C127-4FFB-9275-F007B4DF3279

Q37277441-849CC9B8-D8AE-4F8F-B566-0A904A9F2ADC

P304

Q37277441-29F7489F-39B3-4616-92B0-CF32666A4FA3

P31

Q37277441-3B55F69B-027E-4D5A-B608-B33C1C6F32F8

P356

Q37277441-058A26C8-4742-46BA-B005-2211256BA66E

P407

Q37277441-FAE46DFD-F44F-4330-AAFA-7B5F88A14E19

P433

Q37277441-559F31C6-1E26-4565-AE6B-1BF326ED34EC

P478

Q37277441-AF265679-3EB7-455F-9723-B88BC2F8D30C

P50

Q37277441-AE37DE6E-4EEB-44E3-BB69-5E4981955E43

P577

Q37277441-830CB500-7340-47D6-B275-84B10EA0C2FF

P698

Q37277441-18103795-D679-4595-9E31-1EE9F53DBF8B

P921

Q37277441-459B59DA-CA8A-4778-A1D6-7A0926AEEAF3

Q37277441-E6FF3FF0-86BA-4613-8E1D-6AD0C5A24588

P932

Q37277441-008CAB17-82B9-4AAA-9384-4BDFB9D9417B

P356

1078-0432.CCR-10-1628

P1433

Clinical Cancer Research

P1476

Conditionally replicating adenovirus expressing TIMP2 for ovarian cancer therapy.

@en

P2093

Angel A Rivera

http://www.w3.org/2001/XMLSchema#string

James J Cody

http://www.w3.org/2001/XMLSchema#string

Joanne T Douglas

http://www.w3.org/2001/XMLSchema#string

Kristopher J Kimball

http://www.w3.org/2001/XMLSchema#string

Minghui Wang

http://www.w3.org/2001/XMLSchema#string

Reinhard Waehler

http://www.w3.org/2001/XMLSchema#string

Ronald A Alvarez

http://www.w3.org/2001/XMLSchema#string

Selvarangan Ponnazhagan

http://www.w3.org/2001/XMLSchema#string

Sherry W Yang

http://www.w3.org/2001/XMLSchema#string

P2860

Isolation of a common receptor for Coxsackie B viruses and adenoviruses 2 and 5

Matrix Metalloproteinase Inhibitors and Cancer--Trials and Tribulations

Matrix metalloproteinases and tissue inhibitors of metalloproteinases: structure, function, and biochemistry

An adenovirus vector with genetically modified fibers demonstrates expanded tropism via utilization of a coxsackievirus and adenovirus receptor-independent cell entry mechanism.

Gene delivery from replication-selective viruses: arming guided missiles in the war against cancer.

Genetic targeting of adenoviral vectors.

Critical appraisal of the use of matrix metalloproteinase inhibitors in cancer treatment.

Cancer gene therapy with tissue inhibitors of metalloproteinases (TIMPs).

Metalloproteinase inhibitors: biological actions and therapeutic opportunities.

Altered balance between matrix metalloproteinases and their inhibitors in experimental biliary fibrosis.

P304

538-549

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1158/1078-0432.CCR-10-1628

http://www.w3.org/2001/XMLSchema#string

P407

P433

3

http://www.w3.org/2001/XMLSchema#string

P478

17

http://www.w3.org/2001/XMLSchema#string

P50

P577

2010-11-29T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

21115652

http://www.w3.org/2001/XMLSchema#string

P921

P932

3816714

http://www.w3.org/2001/XMLSchema#string